SGN-CD33A
Biological
Seattle Genetics, Inc.
Total Payments
$1.9M
Transactions
470
Doctors
34
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $1.9M | 470 | 34 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.9M | 436 | 98.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,537 | 8 | 0.9% |
| Consulting Fee | $4,500 | 1 | 0.2% |
| Food and Beverage | $1,752 | 25 | 0.1% |
Payments by Type
Research
$1.9M
436 transactions
General
$23,789
34 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SG0CD33A0004 | Seattle Genetics, Inc. | $769,165 | 0 |
| SG0CD33A0005 | Seattle Genetics, Inc. | $670,618 | 0 |
| SG0CD33A0002 | Seattle Genetics, Inc. | $131,529 | 0 |
| SG0CD33A0001 | Seattle Genetics, Inc. | $120,944 | 0 |
| SG0CD33A0003 | Seattle Genetics, Inc. | $89,661 | 0 |
| SG0CD33A0006 | Seattle Genetics, Inc. | $75,329 | 0 |
| SG0CD33A0007 | Seattle Genetics, Inc. | $6,300 | 0 |
Top Doctors Receiving Payments for SGN-CD33A — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Boston, MA | $70.09 | 1 |
| , M.D | Procedural Dermatology | Detroit, MI | $70.09 | 1 |
| Thomas Waldmann | — | Silver Spring, MD | $70.09 | 1 |
| , MD | Medical Oncology | New York, NY | $70.09 | 1 |
| , MD | Dermatopathology | Chicago, IL | $70.09 | 1 |
| , M.D | Hematology & Oncology | Scottsdale, AZ | $70.09 | 1 |
| , MD | Internal Medicine | Indianapolis, IN | $70.09 | 1 |
| , MD | Medical Oncology | New Haven, CT | $70.09 | 1 |
| , M.D | Dermatology | Houston, TX | $70.09 | 1 |
| , MD | Hematology & Oncology | Los Angeles, CA | $36.90 | 1 |
Ad
Manufacturing Companies
- Seattle Genetics, Inc. $1.9M
Product Information
- Type Biological
- Total Payments $1.9M
- Total Doctors 34
- Transactions 470
About SGN-CD33A
SGN-CD33A is a biological associated with $1.9M in payments to 34 healthcare providers, recorded across 470 transactions in the CMS Open Payments database. The primary manufacturer is Seattle Genetics, Inc..
Payment data is available from 2017 to 2017. In 2017, $1.9M was paid across 470 transactions to 34 doctors.
The most common payment nature for SGN-CD33A is "Unspecified" ($1.9M, 98.7% of total).
SGN-CD33A is associated with 7 research studies, including "SG0CD33A0004" ($769,165).